Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-29

Clinical Trial Update: Anisodamine Critically Ill SeptIc Shock [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update for anisodamine in critically ill patients with septic shock; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • anisodamine (anisodamine)

Snippet

Sponsor: Jinhua Central Hospital | Conditions: Septic Shock | Phase 1, Phase 2 | Status: COMPLETED